 |
 |
 |
 |
 |
 |
 |
- A C D E F H I L M N P Q R S T V -
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Alendronate |
UPLC/MS/MS |
Human plasma |
1.40 |
ng/mL |
| Alendronate |
HPLC/FD |
Human urine |
59.30 |
ng/mL |
| Amitriptyline |
UPLC/MS/MS |
Human plasma |
1.00 |
ng/mL |
| Amlodipine |
HPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Amlodipine |
UPLC/MS/MS |
Human plasma |
0.30 |
ng/mL |
| Amoxicillin |
HPLC/MS/MS |
Human plasma |
0.10 |
µg/mL |
| Azithromycine |
HPLC/MS/MS |
Human plasma |
2.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Cefalexine |
UPLC/PDA |
Human plasma |
0.50 |
µg/mL |
| Celecoxib |
UPLC/MS/MS |
Human plasma |
9.22 |
ng/mL |
| Cetirizine |
HPLC/MS/MS |
Human plasma |
10.60 |
ng/mL |
| Chlormadinone |
UPLC/MS/MS |
Human plasma |
50.20 |
pg/mL |
| Clavulanic Acid |
HPLC/MS/MS |
Human plasma |
0.05 |
µg/mL |
| Clomipramine |
HPLC/MS/MS |
Human plasma |
0.50 |
µg/mL |
| Curcumine |
HPLC/MS/MS |
Human plasma |
5.00 |
ng/mL |
| Curcumine |
HPLC/MS/MS |
Horse plasma |
5.28 |
ng/mL |
| Cyproterone |
UPLC/MS/MS |
Human plasma |
100.20 |
pg/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Desloratadine |
UPLC/MS/MS |
Human plasma |
0.15 |
ng/mL |
|
Desogestrel |
UPLC/MS/MS |
Human plasma |
10.06 |
pg/mL |
| Diclofenac |
HPLC/MS/MS |
Human plasma |
10.00 |
ng/mL |
| Donepezil |
UPLC/MS/MS |
Human plasma |
0.10 |
ng/mL |
| Drospirenone |
UPLC/MS/MS |
Human plasma |
126.25 |
pg/mL |
| Dutasteride |
UPLC/MS/MS |
Human plasma |
50.00 |
pg/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Enalapril |
HPLC/MS/MS |
Human plasma |
2.54 |
ng/mL |
| Enalaprilat |
HPLC/MS/MS |
Human plasma |
2.53 |
ng/mL |
| Erythromycin |
UPLC/MS/MS |
Human plasma |
20.00 |
ng/mL |
| Esomeprazole |
HPLC/MS/MS |
Human plasma |
5.50 |
ng/mL |
| Ethinyl estradiol |
UPLC/MS/MS |
Human plasma |
0.99 |
pg/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Fenofibrate |
UPLC/MS/MS |
Human plasma |
50.00 |
ng/mL |
| Fluconazole |
UPLC/MS/MS |
Human plasma |
100.20 |
ng/mL |
| Flunarizine |
UPLC/MS/MS |
Human plasma |
1.00 |
ng/mL |
| Furosemide |
UPLC/PDA |
Human plasma |
20.90 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Hydrochlorothiazide |
HPLC/MS/MS |
Human plasma |
2.50 |
ng/mL |
| Hydrochlorothiazide |
UPLC/MS/MS |
Human plasma |
1.94 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Ibandronate |
HPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Itraconazole |
UPLC/UV |
Human plasma |
5.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Leflunomide |
UPLC/UV |
Human plasma |
0.08 |
µg/mL |
| Lorazepam |
HPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Losartan |
UPLC/MS/MS |
Human plasma |
4.67 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Meloxicam |
HPLC/UV |
Human plasma |
10.00 |
ng/mL |
| Memantina |
UPLC/MS/MS |
Human plasma |
0.10 |
ng/mL |
|
Mycophenolate mofetil |
UPLC/MS/MS |
Human plasma |
20.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Nifedipine |
UPLC/PDA |
Human plasma |
10.10 |
ng/mL |
| Nifedipine |
UPLC/MS/MS |
Human plasma |
0.50 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Pantoprazole |
UPLC/UV |
Human plasma |
41.40 |
ng/mL |
| Paracetamol |
HPLC/MS/MS |
Human plasma |
0.10 |
µg/mL |
| Prednisone (Prednisolone) |
UPLC/MS/MS |
Human plasma |
20.80 |
ng/mL |
| Pregabalin |
UPLC/MS/MS |
Human plasma |
25.00 |
ng/mL |
| Pyridylacetic Acid |
HPLC/MS/MS |
Human plasma |
10.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Quetiapine |
HPLC/MS/MS |
Human plasma |
1.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Racecadotril (Thiorfan) |
UPLC/MS/MS |
Human plasma |
1.50 |
ng/mL |
| Repaglinide |
UPLC/MS/MS |
Human plasma |
0.50 |
ng/mL |
| Rifaximin |
HPLC/MS/MS |
Human plasma |
0.50 |
ng/mL |
| Rifaximin |
HPLC/UV |
Human urine |
10.00 |
ng/mL |
| Rifaximin |
UPLC/PDA |
Human faeces |
31.50 |
µg/mL |
| Rifaximin |
HPLC/MS/MS |
Dog plasma |
0.25 |
ng/mL |
| Risedronate |
UPLC/MS/MS |
Human serum |
0.20 |
ng/mL |
| Rivastigmine |
HPLC/MS/MS |
Human plasma |
0.30 |
ng/mL |
| Rosuvastatine |
UPLC/MS/MS |
Human plasma |
1.00 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Sibutramine |
UPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Sibutramine (M1) |
UPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Sibutramine (M2) |
UPLC/MS/MS |
Human plasma |
0.20 |
ng/mL |
| Silybin A free |
UPLC/MS/MS |
Human plasma |
2.39 |
ng/mL |
| Silybin B free |
UPLC/MS/MS |
Human plasma |
2.63 |
ng/mL |
| Silybin A total |
UPLC/MS/MS |
Human plasma |
24.00 |
ng/mL |
| Silybin B total |
UPLC/MS/MS |
Human plasma |
26.40 |
ng/mL |
| Silybin A free |
UPLC/MS/MS |
Human urine |
5.66 |
ng/mL |
| Silybin B free |
UPLC/MS/MS |
Human urine |
6.22 |
ng/mL |
| Simvastatin |
UPLC/MS/MS |
Human plasma |
0.10 |
ng/mL |
| Spironolactone |
UPLC/MS/MS |
Human plasma |
0.51 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Tramadol |
HPLC/MS/MS |
Human plasma |
2.01 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
|
R&D Labs S.r.l. |
||||
| Compound |
Bioanalytical Method |
Bioanalytical Matrix |
LLOQ |
Unit |
| Valaciclovir (Aciclovir) |
UPLC/UV |
Human plasma |
20.30 |
ng/mL |
| Valaciclovir (Aciclovir) |
HPLC/MS/MS |
Human plasma |
20.08 |
ng/mL |
| Valsartan |
HPLC/MS/MS |
Human plasma |
49.80 |
ng/mL |
| Valsartan |
UPLC/MS/MS |
Human plasma |
40.00 |
ng/mL |
| Venlafaxine |
UPLC/MS/MS |
Human plasma |
1.80 |
ng/mL |
|
Molecule |
Analytical Methods |
|||
Go back to the top of the page
R&D Labs S.r.l. - Copyright © 2005-2011 - All Rights Reserved - P.IVA 09921360153 - C.F. 01640980122